Skip to main content

Table 1 Breast cancer cases with equivocal HER2 status.

From: Clinical array-based karyotyping of breast cancer with equivocal HER2 status resolves gene copy number and reveals chromosome 17 complexity

Case

Reason for Referral

HER2 status by array CGH

FIR Value

EQ-1

Equivocal by FISH; Polysomy?

Negative

1.18

EQ-2

Equivocal by IHC and FISH

Positive

1.47

EQ-3

Equivocal by IHC and FISH

Positive

2.36

EQ-4

Equivocal; HER2 polyploidy?

Negative

1.09

EQ-5

HER2+; HER2/centromere co-amplification?

Positive

3.06

EQ-6

Equivocal by FISH pericentromeric monosomy?

Negative

1.23

EQ-7

Equivocal by FISH; aneusomy?

Negative

1.19

EQ-8

Equivocal by FISH; aneusomy?

Negative

0.81

EQ-9

Equivocal by FISH; aneusomy?

Negative

1.00

EQ-10

Equivocal by IHC and FISH

Negative

0.92

EQ-11

Equivocal by IHC and FISH

Negative

1.02

EQ-12

HER2+; centromeric amplification?

Positive

4.23

EQ-13

HER2+ by IHC; polysomy?

Positive (false - by FISH)

1.35

EQ-14

Equivocal

Negative

0.81

EQ-15

Equivocal by IHC and FISH

Negative

1.00

EQ-16

Discordant: IHC 1+, FISH 2.86

Negative (false + by FISH)

0.97

EQ-17

2.7 "interpret with caution due to monosomy 17"

Negative (false + by FISH)

1.15

EQ-18

Resolve equivocal IHC, FISH, and OncotypeDX®

Positive

1.67

EQ-19

Equivocal by IHC and FISH

Negative

0.97

EQ-20

Resolve equivocal IHC, FISH and OncotypeDx®

Positive

3.70

  1. Reason for referral and array CGH findings are summarized in twenty cases of invasive ductal carcinoma. HER2 and chromosome 17 status were determined by array CGH as determined by fluorescence intensity ratio (FIR) value. Two cases (EQ 18 and EQ 20) were also equivocal by OncotypeDX® (Genomic Health, Redwood City, CA).